Skip to main content

Daniel J. Morgan, MD, M.S.

Academic Title:


Primary Appointment:

Epidemiology & Public Health

Secondary Appointment(s):



685 W. Baltimore St., MSTF 334

Phone (Primary):

(410) 706-1734

Phone (Secondary):

(410) 706-0098

Education and Training

BS Psychology, Reed College, Portland, Oregon                             

MD with Distinction in Research, University of Rochester, Rochester, New York

MS Clinical Research, University of Maryland School of Medicine, Baltimore, Maryland


Daniel Morgan MD, MS is a physician and epidemiologist in Baltimore, Maryland. He is a tenured Professor of Epidemiology and Medicine at the University of Maryland School of Medicine where the directs the Center for Innovation in Diagnosis and is Chief of Epidemiology at the VA Maryland Healthcare System. 

He was a founding member and past Director of the Society for Healthcare Epidemiology of America (SHEA) Research Network and was on the Board of Directors of SHEA. He is incoming SHEA Chair for IDWeek 2022. At the VA Maryland Healthcare System he directs Epidemiology with a team of 5 physicians and 6 nurses. 

His research explores probability in medicine, medical overuse, diagnostic stewardship and infection prevention. On a NIH New Innovator award for "exceptional scientists pursing highly innovative approaches to major challenges" he is exploring clinician risk understanding. This has led to creation of site. 

He has continuous federal funding, over 170 publications and his work often appears in the media including New York Times, Washington Post and the Economist. 

Highlighted Publications

  1. Harris AD, Pineles L, Belton B, Johnson JK, Shardell M, Loeb M, Newhouse R, Dembry L, Braun B, Perencevich EN, Hall KK, Morgan DJ and the Benefits of Universal Glove and Gown (BUGG) Investigators. Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA 2013;310(15):1571-80. 
  2. Morgan DJ, Kaye KS, Diekema DJ. Reconsidering isolation precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. JAMA 2014;312(14):1395-6. 
  3. Morgan DJ, Brownlee S, Leppin AL, Kressin N, Dhruva SS, Levin L, Landon BE, Zezza MA, Schmidt H, Saini V, Elshaug AG. Setting a research agenda for medical overuse. BMJ. 2015;351:h4534. 
  4. Morgan DJ, Malani P, Diekema DJ. Diagnostic Stewardship-Leveraging the Laboratory to Improve Antimicrobial Use. JAMA. 2017 Jul 31.
  5. Morgan DJ, Pineles L, Owczarzak J, Magder L, Scherer L, Brown JP, Pfeiffer C, Terndrup C, Leykum L, Feldstein D, Foy A, Stevens D, Koch C, Masnick M, Weisenberg S, Korenstein D. Accuracy of clinician estimates of probability of diagnosis before and after testing. JAMA Intern Med. 2021

Clinical Specialty Details

Infectious Diseases

Hospital Medicine

Long-term care

Hospital Epidemiology

Awards and Affiliations

NIH Director's New Innovator Award from the Common Fund's High-Risk, High-Reward Research Program 2017

Councilor, Board of Directors, Society for Healthcare Epidemiology of America (SHEA) 2017-2018

Grants and Contracts

NIH NLM DP2LM012890 (New Innovator Award)Incorporating Bayesian reasoning into physician testing and treatment decisions   

AHRQ R01 HS025456-01 Understanding and preventing Clostridium difficile transmission from asymptomatically colonized patient

CDC 1U54CK000-450  (Harris PI) Epicenters for the Prevention of Healthcare-Associated Infections.